Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

for
Gastric Cancer, Gastrointestinal Cancer, HER2 Gene Mutation
Location: Palo Alto CA, Buffalo NY, Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT05274048

Phase 1, Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

for
Prostatic Neoplasms, Castration-Resistant
Location: Stanford CA, Omaha NE, Rochester MN, St Louis MO,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT04868604

Phase 1, Phase 2, Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

for
Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML,
Location: Palo Alto CA, Sacramento CA, Los Angeles CA, Irvine CA,
Sponsor: Aptose Biosciences Inc.

Sex: All

Age: 18+

Code: NCT03850574

Phase 1, Phase 2, Recruiting

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Palo Alto CA, San Antonio TX, Toronto, Fairfax VA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06532565

Phase 1, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Stanford CA, Sacramento CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

for
Gastrointestinal Stromal Tumor (GIST),
Location: Palo Alto CA, Santa Monica CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06655246

Phase 1, Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Palo Alto CA, Milwaukee WI, Chicago IL, Atlanta GA,
Sponsor: Ichnos Sciences SA

Sex: All

Age: 18+

Code: NCT05862012

Phase 1, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Stanford CA, Sacramento CA, Orange CA, Seattle WA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Palo Alto CA, Aurora CO, Minneapolis MN, Memphis TN,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase 1, Phase 2, Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Palo Alto CA, Los Angeles CA, Duarte CA, Seattle WA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase 1, Recruiting

Improving Overactive Bladder Treatment Access and Adherence

for
Overactive Bladder Syndrome, Urinary Incontinence
Location: Redwood City CA
Sponsor: Stanford University

Sex: Female

Age: 18+

Code: NCT06094543

Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Stanford CA, Seattle WA, Aurora CO, Houston TX,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase 1, Phase 2, Recruiting

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

for
Sezary Syndrome, Mycosis Fungoides
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT04256018

Phase 2, Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

for
Metastatic Malignant Solid Neoplasm, Metastatic Melanoma,
Location: Stanford CA, Los Angeles CA, Duarte CA
Sponsor: Anusha Kalbasi

Sex: All

Age: 18 - 70+

Code: NCT04119024

Phase 1, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Stanford CA, Los Angeles CA, Tucson AZ, Houston TX,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase 1, Phase 2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: Palo Alto CA, Santa Monica CA, Scottsdale AZ, Tucson AZ,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Palo Alto CA, Los Angeles CA, La Jolla CA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

for
Hodgkin Lymphoma
Location: Stanford CA, Vancouver, Winnipeg, Hamilton, Toronto,
Sponsor: University College, London

Sex: All

Age: 16 - 69

Code: NCT04685616

Phase 3, Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for
Low Risk Myelodysplastic Syndromes
Location: Palo Alto CA, Los Angeles CA, Orange CA,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05308264

Phase 1, Phase 2, Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Palo Alto CA, Duarte CA, Westwood KS, Houston TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase 1, Recruiting